Share on LinkedInShare on LinkedIn

ARTICLE · 16 OCTOBER 2023

What Rescheduling To Schedule III Would Mean For The Cannabis Industry

Carter Ledyard & Milburn LLP
Carter Ledyard & Milburn LLP
Contributor
Carter Ledyard & Milburn LLP

Carter Ledyard & Milburn LLP

Carter Ledyard & Milburn is a general practice law firm headquartered in the Financial District....

View firm profile
Explore more from Carter Ledyard & Milburn LLP

Cannabis is currently listed as a Schedule I controlled substance under the CSA. Schedule I substances are defined as drugs with no currently accepted medical use and a high potential for abuse...

United StatesCannabis & Hemp

September 12, 2023 - Last month, Bloomberg reported that it had obtained a letter from the Department of Health and Human Services (HHS) recommending that the U.S. Drug Enforcement Agency (DEA) reclassify cannabis from Schedule I of the Controlled Substances Act (CSA) to Schedule III. The report includes confirmation from a DEA spokesperson that the letter with the recommendation was received, but as of the writing of this article, the letter has not been made public. "US Health Officials Urge Moving Pot to Lower-Risk Tier," Bloomberg, Aug. 30, 2023.

The letter comes some 10 months after President Biden called on the Secretary of HHS and the Attorney General to "expeditiously" review the scheduling of cannabis under federal law and, if adopted, would represent the biggest change in federal cannabis policy in 40 years.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from